Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue.
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
A
A
Ghavamzadeh
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
K
K
Alimoghaddam
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
M
M
Jalili
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
S A
SA
Mousavi
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
B
B
Bahar
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.|Non-communicable Diseases Research Center, Endocrinology & Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
A
A
Kasaeian
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
A A
AA
Hamidieh
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
M
M
Behfar
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
M
M
Vaezi
Tehran University of Medical Sciences, Tehran, Iran.
A
A
Jalali
Hematology-Oncology and Stem Cell Transplantation Research Center/Tehran University of Medical Sciences, Tehran, Iran.
M
M
Jahani
D000293:Adolescent; D000741:Anemia, Aplastic / Q000628:therapy*; D018952:Antigens, CD34 / Q000378:metabolism; D016026:Bone Marrow Transplantation / Q000379:methods*; D003520:Cyclophosphamide / Q000627:therapeutic use; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006680:HLA Antigens / Q000737:chemistry; D019650:Hematopoietic Stem Cell Mobilization; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006760:Hospitalization; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D015999:Multivariate Analysis; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D016016:Proportional Hazards Models; D012306:Risk; D019172:Transplantation Conditioning / Q000379:methods; D016896:Treatment Outcome; D055815:Young Adult
D018952:Antigens, CD34; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide
Semin Hematol. 2000 Jan;37(1):30-42
10676909
Bone Marrow Transplant. 2001 Apr;27(8):785-90
11477434
Br J Haematol. 2003 Dec;123(5):782-801
14632769
Haematologica. 2012 Aug;97(8):1142-8
22315497
Hematology Am Soc Hematol Educ Program. 2012;2012:292-300
23233595
Blood. 2002 Mar 15;99(6):2037-44
11877277
Haematologica. 2008 Apr;93(4):489-92
18379007
Blood. 2001 Nov 15;98(10):2900-8
11698269
Blood. 2006 Oct 15;108(8):2509-19
16778145
N Engl J Med. 1999 Jul 1;341(1):14-21
10387937
Lancet. 1987 Oct 24;2(8565):955-7
2889870
Blood. 2007 Aug 15;110(4):1397-400
17475907